Clinical Trials Browser

Phase 1 × OTHER × Metastatic Castrate- Resistant Prostate Cancer × Clear all

NCT03041285 2022-05-11

Idronoxil Suppository Combine With Radiotherapy for Metastatic Prostate Cancer

Phase 1 Terminated

Metastatic Castrate- Resistant Prostate Cancer